These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2630570)

  • 21. Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.
    Tan P; Pang G; Wilson JD
    Clin Exp Immunol; 1981 Jun; 44(3):548-54. PubMed ID: 6799237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of in vitro lymphoproliferative responses among HTLV-1-infected subjects: upregulation by HTLV-1 during HIV-1 co-infection.
    Olah I; Fukumori LM; Montanheiro P; Vergara MP; Smid J; Duarte AJ; Penalva de Oliveira AC; Casseb J
    Scand J Immunol; 2007 Jun; 65(6):577-80. PubMed ID: 17523951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive factor produced by a B cell line derived from an adult T cell leukemia patient.
    Mori N; Yamashita U; Tanaka Y; Nagata K; Nakata K; Oda S; Eto S
    Int J Hematol; 1992 Aug; 56(1):29-39. PubMed ID: 1391804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New Orleans.
    deShazo RD; Chadha N; Morgan JE; Shorty VJ; Rangan SR; Kalyanaraman VS; Hyslop N; Chapman Y; O'Dea S
    Am J Med; 1989 Jan; 86(1):65-70. PubMed ID: 2521277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell independence of immunoglobulin synthesis by human peripheral blood lymphocytes stimulated with SpA-containing staphylococci.
    Romagnani S; Del Prete GF; Maggi E; Falagiani P; Ricci M
    Immunology; 1980 Dec; 41(4):921-7. PubMed ID: 6970168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers.
    Akimoto M; Kozako T; Sawada T; Matsushita K; Ozaki A; Hamada H; Kawada H; Yoshimitsu M; Tokunaga M; Haraguchi K; Uozumi K; Arima N; Tei C
    J Med Virol; 2007 Jul; 79(7):977-86. PubMed ID: 17516523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenetic significance of HTLV-I infection and immune surveillance in HAM].
    Fujihara K
    Rinsho Shinkeigaku; 1999 Jan; 39(1):21-3. PubMed ID: 10377790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell surface antigen expression in cultured lymphocytes derived from healthy HTLV-I carriers.
    Sei Y; Yasuda K; Hara A; Yasuda K; Yokoyama MM
    J Clin Lab Immunol; 1986 Feb; 19(2):71-5. PubMed ID: 2420987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
    Kannagi M; Harada S; Maruyama I; Inoko H; Igarashi H; Kuwashima G; Sato S; Morita M; Kidokoro M; Sugimoto M
    Int Immunol; 1991 Aug; 3(8):761-7. PubMed ID: 1911545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
    Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
    J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced inhibition of lymphocyte activation by Mycobacterium avium complex in human T lymphotrophic virus type I carriers.
    Matsuyama W; Kubota R; Hamasaki T; Mizoguchi A; Iwami F; Wakimoto J; Kawabata M; Osame M
    Thorax; 2001 May; 56(5):394-7. PubMed ID: 11312409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in T cell phenotype and activated MAPKs are correlated to impaired cellular responses to antigens and glucocorticoids during HTLV-I infection.
    Pillat MM; Correa BL; da Rocha CF; Müller GC; Lopes RP; Lampert SS; Teixeira AL; Menna-Barreto M; Bauer ME
    J Neuroimmunol; 2009 Nov; 216(1-2):76-84. PubMed ID: 19766325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors.
    Katahira Y; Yashiki S; Fujiyoshi T; Nomura K; Tara M; Mori M; Setoyama M; Kanzaki T; Shida H; Sonoda S
    Jpn J Cancer Res; 1995 Jan; 86(1):21-7. PubMed ID: 7537726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.
    Pahwa S; Pahwa R; Saxinger C; Gallo RC; Good RA
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8198-202. PubMed ID: 2999797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4
    Makiyama J; Kobayashi S; Watanabe E; Ishigaki T; Kawamata T; Nakashima M; Yamagishi M; Nakano K; Tojo A; Watanabe T; Uchimaru K
    Cancer Sci; 2019 Dec; 110(12):3746-3753. PubMed ID: 31642546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1.
    Seki M; Higashiyama Y; Kadota J; Mukae H; Yanagihara K; Tomono K; Kohno S
    Chest; 2000 Dec; 118(6):1754-61. PubMed ID: 11115469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-1 carriers with B-cell lymphoma of localized stage head and neck: prognosis, clinical and immunopathological features.
    Suefuji H; Ohshima K; Hayabuchi N; Nakamura K; Kikuchi M
    Br J Haematol; 2003 Nov; 123(4):606-12. PubMed ID: 14616963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.